Enzon Pharmaceuticals Inc

Enzon Pharmaceuticals Inc

ENZN

Market Cap$6.01M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Enzon Pharmaceuticals IncEnzon Pharmaceuticals Inc-91.1--3%-0.2
$0.63

Current Fair Value

443.3% upside

Undervalued by 443.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$6.01 Million
Enterprise Value$-38,623,617.00
Dividend Yield$0 (0%)
Earnings per Share$-0.01
Beta0.24
Outstanding Shares74,215,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-91.08
PEG34.53
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-1485.52
Enterprise Value to EBIT-254.1
Enterprise Value to Net Income585
Total Debt to Enterprise-0.01
Debt to Equity0.17

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Enzon Pharmaceuticals Inc

CEO: Andrew Rackear

Enzon Pharmaceuticals, Inc is a pharmaceutical company engaged in developing therapeutics to patients whose needs are unmet. Its headquarters is now in Piscataway, New Jersey. The company is a publicly traded company on NASDAQ under the ...